Merck & Co., Inc. Comprehensive Income 2007-2026 | MRK
Beta
What is comprehensive income?
Comprehensive income includes net income plus other comprehensive items like foreign currency adjustments and unrealized investment gains or losses.
What is Merck & Co., Inc.'s current comprehensive income?
Merck & Co., Inc. (MRK) annual comprehensive income for 2025 was $18.91B, a 9.11% increase from 2024. Merck & Co., Inc. comprehensive income for the quarter ending March 31, 2026 was $-4.01B.
What was Merck & Co., Inc.'s comprehensive income in 2024?
Merck & Co., Inc. annual comprehensive income for 2024 was $17.33B, a 62003.57% increase from 2023.
What was Merck & Co., Inc.'s comprehensive income in 2023?
Merck & Co., Inc. annual comprehensive income for 2023 was $-28.0M, a 100.20% decline from 2022.
What is Merck & Co., Inc.'s 5-year comprehensive income CAGR?
Merck & Co., Inc. comprehensive income grew at a compound annual growth rate (CAGR) of 23.34% from FY2020 to FY2025, going from $6.63B to $18.91B over 5 years.
Comprehensive Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+23.3%
FY2020
$6.63B
→
FY2025
$18.91B
07080910111213141516171819202122232425
5 years selected
Comprehensive Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $18.91B | +9.1% | 10-K |
| FY2024 | $17.33B | +62003.6% | 10-K |
| FY2023 | $-28.0M | -100.2% | 10-K |
| FY2022 | $14.18B | -4.2% | 10-K |
| FY2021 | $14.80B | +123.4% | 10-K |
| FY2020 | $6.63B | -27.9% | 10-K |
| FY2019 | $9.20B | +56.9% | 10-K |
| FY2018 | $5.86B | +116.2% | 10-K |
| FY2017 | $2.71B | -4.6% | 10-K |
| FY2016 | $2.84B | -38.4% | 10-K |
| FY2015 | $4.62B | -52.9% | 10-K |
| FY2014 | $9.79B | +42.2% | 10-K |
| FY2013 | $6.89B | +49.2% | 10-K |
| FY2012 | $4.62B | -27.3% | 10-K |
| FY2011 | $6.36B | +1442.7% | 10-K |
| FY2010 | $412.0M | -96.8% | 10-K |
| FY2009 | $12.69B | +108.7% | 10-K |
| FY2008 | $6.08B | +68.3% | 10-K |
| FY2007 | $3.61B | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →